Process for making lysine-glutamic acid dipeptide derivatives

US9802886B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9802886-B2
Application numberUS-201615348093-A
CountryUS
Kind codeB2
Filing dateNov 10, 2016
Priority dateMay 15, 2012
Publication dateOct 31, 2017
Grant dateOct 31, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to compounds of the formula and to a process for making same and to the use of the products in the solid phase peptide synthesis. The compounds of formula I are versatile peptide intermediates for the solid phase peptide synthesis (SPPS) of peptide drugs which comprise a Glu-fatty alkyl side chain building block attached to a Lys-part of the peptide chain.

First claim

Opening claim text (preview).

The invention claimed is: 1. A process for the preparation of compounds of formula I, and enantiomers and salts thereof, wherein: R 1 is hydrogen or an ester protecting group; R 2 is hydrogen; R 3 is hydrogen or an amino protecting group and R 4 is C 12-20 -alkyl; the process comprising: a) coupling the glutamic acid derivative of formula II or a salt thereof with a lysine derivative of formula III wherein R 2′ is an ester protecting group, or a salt thereof to form a compound of the formula Ic; and b) removing the ester protecting group R 2′ to provide the compound of formula I. 2. The process of claim 1 , wherein the ester protecting group is selected from C 1-4 -alkyl, optionally substituted with phenyl, C 2-4 -alkenyl, piperidinyl or dimethylaminoboranyl. 3. The process of claim 1 , wherein R 1 is hydrogen or C 1-4 -alkyl. 4. The process of claim 1 , wherein R 1 is C 1-4 -alkyl. 5. The process of claim 1 , wherein R 1 is hydrogen. 6. The process of claim 1 , wherein R 3 is 9H-fluoren-9-ylmethoxycarbonyl. 7. The process of claim 1 , wherein R 1 is t-butyl. 8. The process of claim 1 , wherein R 4 is C 14-16 -alkyl. 9. The process of claim 1 , wherein R 4 is C 15 -alkyl. 10. The process of claim 1 , wherein R 4 is pentadecyl. 11. The process of claim 1 , wherein R 3 is 9H-fluoren-9-ylmethoxycarbonyl and R 4 is C 15 -alkyl. 12. The process of claim 1 , wherein R 3 is 9H-fluoren-9-ylmethoxycarbonyl and R 4 is pentadecyl. 13. The process of claim 1 , wherein the compound of formula I is a compound of formula Ia 14. The process of claim 1 , wherein the compound of formula I is a compound of formula Ib 15. The process of claim 1 , wherein the coupling of the glutamic acid derivative of formula II with the lysine derivative of formula III is carried out by solid phase synthesis. 16. The process of claim 1 , wherein the coupling of the glutamic acid derivative of formula II with the lysine derivative of formula III is carried out by FMOC solid phase synthesis.

Assignees

Inventors

Classifications

  • C07C271/22Primary

    to carbon atoms of hydrocarbon radicals substituted by carboxyl groups · CPC title

  • C07C269/06Primary

    by reactions not involving the formation of carbamate groups · CPC title

  • Fluorenes; Hydrogenated fluorenes · CPC title

  • and aliphatic · CPC title

  • Chemical, physical or physico-chemical processes in general; Their relevant apparatus · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9802886B2 cover?
The invention relates to compounds of the formula and to a process for making same and to the use of the products in the solid phase peptide synthesis. The compounds of formula I are versatile peptide intermediates for the solid phase peptide synthesis (SPPS) of peptide …
Who is the assignee on this patent?
Hoffmann La Roche
What technology area does this patent fall under?
Primary CPC classification C07C271/22. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).